A phase II study of resection followed capecitabine + oxaliplatin for liver metastasis of colorectal cancer. [REX study]
收藏NIAID Data Ecosystem2026-03-08 收录
官方服务：
资源简介：
Interventions: Surgical hepatectomy followed by chemotherapy (XELOX)8cycles. (L-OHP 130 mg/m2 day1 , Capecitabine 2,000mg/m2/day day1-14) Primary outcome(s): 3-year Disease-Free Survival Study Design: Single arm Non-randomized
创建时间：
2014-02-15
